Sonitor Technologies Names Carl Christian Gilhuus-­Moe and Hans Thomas Holbye to Board of Directors

RTLS Technology Innovator Continues To  Build Highly Experienced Governance and Leadership Team

Stamford (January 13, 2015) Sonitor Technologies, the global RTLS technology innovator, today announced that it has appointed Carl Christian Gilhuus-­‐Moe and Hans Thomas Holbye to its board of directors.  Gilhuus-­‐Moe and Holbye bring substantial global medical technology, business  and finance experience  to  the Sonitor board.   

A seasoned medical technologist and executive, Carl Christian Gilhuus-­‐Moe, PhD, trained at the  Swedish  Institute  of Management, the Sloan School of Management at the Massachusetts Institute of Technology  and  earned  his  PhD in biochemistry from the University of Oslo. He is the Chairman of the Board of Oslo Medtech, a group of hospital, finance, knowledge  and  research  institutions  focusing  on  medical technology innovation and facilitates development of medtech products and services. Gilhuus-­‐Moe is also a Senior Advisor of NeoMed Management, a Europe-­‐ based venture capital fund focused  on  international  healthcare  and  medical technology. In addition, he sits on the board of directors of JenaValve Technology, GmbH, and has served as a board member of Alertis Medical AS, Clavis Pharma ASA, Harbinger Medical, Inc. and NeoRad AS.  

Previously Gilhuus-­‐Moe served as Chairman of the Board for both SINTEF-­‐Unimed (Norweigian Institute of Technology) and The European Committee for Clinical Laboratory Standardization (ECCLS), as well as a member of the executive group, Vice President and Head of Hafslund Nycomed ASA's diagnostic division.

Hans Thomas Holbye earned an Msc Business and Administration degree from BI Norwegian Business School. He is the Managing Director and CEO of Johs. Hansen Rederi AS and previously served as Finance Manager at IBM Norway and CFO and Head of the Investment Division of The Torvald Klaveness Group. Holbye sits on several Norwegian company boards.   

Per Heidenreich, Sonitor Technologies Executive Chairman of The Board, commented, “We could not be more pleased to add such eminent individuals to our board. Carl Christian and Hans Thomas clearly have a unique blend of technical and global business experience and capabilities that will help steer our growing  company into the future with our strong team of board members and advisors. The timing could not be better as the markets for RTLS in healthcare, hospitality and beyond are gaining momentum.”

Additional members of Sonitor Technologies’ Board of Directors include company founder Ole B. Hovind, M.D. and Per Grobstok , Chairman of Service Invest AS. The

U.S. Advisory Board members include Robert A. Chernow, Founder and President of Educational Services for Entrepreneurship and former President and Chief Executive Officer, New York and Presbyterian Health Plan; James M. Cotter, J.D., Co-­‐ founder of Breedon Capital Management and former Vice Chairman and Partner at Simpson Thacher & Bartlett; David S. Taylor, CIO of Stamford Hospital, and Joe Toce, Managing Director of WTAS. (­‐sno-­‐board)

About Sonitor Technologies

Sonitor Technologies’ tiered resolution Real Time Locations Systems (RTLS), with patented High Definition Ultrasound capabilities, are specifically developed and designed for indoor positioning in complex environments. Sonitor has developed the healthcare industry’s most advanced open integration RTLS platform, Sonitor Sense™, a wireless system which supports a wide range of applications to make hospital operations more efficient. Sonitor is selected by world-­‐class partners to build industry-­‐ leading solutions for global deployment.